Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
12.22
+0.19 (1.58%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Company Description
Oscar Health, Inc. operates as a healthcare technology company in the United States.
The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products.
The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021.
Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc.
Country | United States |
Founded | 2012 |
IPO Date | Mar 3, 2021 |
Industry | Healthcare Plans |
Sector | Healthcare |
Employees | 2,400 |
CEO | Mark Bertolini |
Contact Details
Address: 75 Varick Street, 5th Floor New York, New York 10013 United States | |
Phone | 646 403 3677 |
Website | hioscar.com |
Stock Details
Ticker Symbol | OSCR |
Exchange | NYSE |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $39.00 |
CIK Code | 0001568651 |
CUSIP Number | 687793109 |
ISIN Number | US6877931096 |
SIC Code | 6324 |
Key Executives
Name | Position |
---|---|
Mark Thomas Bertolini | Chief Executive Officer and Director |
Mario Tobias Schlosser | Co-Founder, Chief Technology Officer and Director |
Richard Scott Blackley CPA | Chief Financial Officer |
Ranmali Bopitiya | Executive Vice President of Public Affairs |
Joshua Kushner | Co-Founder and Vice Chairman |
Victoria Baltrus | Chief Accounting Officer |
Chris Potochar | Vice President of Treasury and Investor Relations |
Adam McAnaney | Executive Vice President and Chief Legal Officer |
Rebecca Krouse | Chief People Officer |
Joel I. Klein J.D. | Senior Advisor |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 25, 2025 | ARS | Filing |
Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
Mar 10, 2025 | 144 | Filing |
Mar 7, 2025 | 144 | Filing |
Mar 5, 2025 | 144 | Filing |
Mar 4, 2025 | 144 | Filing |
Mar 3, 2025 | 8-K | Current Report |
Feb 24, 2025 | 144 | Filing |
Feb 21, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |